DEAD

Serial Number

97284796

Owner

Summit Therapeutics Inc.

Attorney

Andrea M. Porterfield

Filing Date

Feb 25, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

SUMMIT THERAPEUTICS Trademark

Serial Number: 97284796

SUMMIT THERAPEUTICS is a trademark filed by Summit Therapeutics Inc. on February 25, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Summit Therapeutics Inc. (4 trademarks)

14th Floor
Cambridge, MA 02142

Entity Type: 03

SUMMIT THERAPEUTICS SUB INC. (14 trademarks)

2882 Sand Hill Road, Suite 106
Menlo Park, CA 94025

Entity Type: 03

Legal Representation

Attorney of Record

Andrea M. Porterfield

1,195 trademarks filed View all →

Correspondence Address

Andrea M. Porterfield POLSINELLI PC

PO BOX 140310

KANSAS CITY, MO 64114-0310

United States

Trademark Details

Filing Date

February 25, 2022

Registration Date

Not Registered

Goods & Services

Pharmaceutical products for the treatment, prevention, prophylaxis, recurrence prevention and diagnosis of disease states and conditions caused or exacerbated by the administration of broad spectrum antibiotics; pharmaceutical products for the treatment, prevention, prophylaxis, recurrence prevention and diagnosis of inflammatory-related diseases, cancers, diseases of the respiratory system, diseases of the central nervous system, neurodegenerative diseases, infectious diseases, gut dysbiosis and microbiome related diseases and conditions; pharmaceutical products for the promotion, restoration, and maintenance of a healthy microbiome

Drug discovery

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Oct 7, 2024 MAB2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Oct 7, 2024 ABN2

NOTIFICATION OF FINAL REFUSAL EMAILED

Mar 6, 2024 GNFN

FINAL REFUSAL E-MAILED

Mar 6, 2024 GNFR

FINAL REFUSAL WRITTEN

Mar 6, 2024 CNFR

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Feb 27, 2024 TCCA

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Feb 27, 2024 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Feb 27, 2024 COAR

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 23, 2024 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 23, 2024 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 23, 2024 TROA

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Nov 22, 2023 XELG

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Nov 22, 2023 XELR

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Oct 25, 2023 ASGN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 25, 2023 GNRN

NON-FINAL ACTION E-MAILED

Aug 25, 2023 GNRT

NON-FINAL ACTION WRITTEN

Aug 25, 2023 CNRT

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Feb 21, 2023 GNS3

LETTER OF SUSPENSION E-MAILED

Feb 21, 2023 GNSL

SUSPENSION LETTER WRITTEN

Feb 21, 2023 CNSL

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 18, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 17, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 17, 2023 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 12, 2022 GNRN

NON-FINAL ACTION E-MAILED

Dec 12, 2022 GNRT

NON-FINAL ACTION WRITTEN

Dec 12, 2022 CNRT

ASSIGNED TO EXAMINER

Dec 9, 2022 DOCK

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

Mar 25, 2022 AMPX

ASSIGNED TO LIE

Mar 24, 2022 ALIE

ASSIGNED TO LIE

Mar 21, 2022 ALIE

NOTICE OF DESIGN SEARCH CODE E-MAILED

Mar 3, 2022 MDSC

TEAS VOLUNTARY AMENDMENT RECEIVED

Mar 2, 2022 PARI

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 2, 2022 NWOS

NEW APPLICATION ENTERED

Mar 1, 2022 NWAP

Related Trademarks

More from this Owner

More in Same Class

Serial #97285726

C+ CPLUS BIOTECH